SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Merck
MRK 99.21+1.0%Dec 17 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: mopgcw10/6/2007 9:05:03 AM
   of 1580
 
Florida Circuit Court Rules
In Merck's Favor Over Vioxx
Associated Press
October 5, 2007 5:07 p.m.

WHITEHOUSE STATION, N.J. -- Drug maker Merck & Co. Inc. said Friday the jury in a Florida liability case involving its painkiller Vioxx decided in the company's favor.

The company said the jury found it was not liable for plaintiff Refik Kozic's heart attack. Mr. Kozic alleged that he used Vioxx for about nine weeks before suffering his heart attack in April 2001 at 50 years old, according to Merck.

It was the first Vioxx case in Florida to go to trial.

Merck pulled its blockbuster drug from the market Sept. 30, 2004, due to increased risk of heart attack and stroke that prompted massive litigation. Soon after that, analysts predicted liability could reach $50 billion. But that hasn't proven true, as the drug maker has won 11 verdicts and lost five so far.

Merck also claimed victory in two multibillion-dollar class-action lawsuits, on behalf of shareholders and private insurers seeking to recoup what they paid for Vioxx prescriptions.

Still, at least 45,200 product liability cases are pending.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext